BTTC News
Friday, February 24, 2012 - 8:00pm
Dr. Mark Gilbert, the Brain Tumor Trials Collaborative (BTTC) principal investigator, presented a state-of-the-BTTC report at the annual BTTC meeting in February at MD Anderson Cancer Center in Houston, Texas.
Highlighting Gilbert’s presentation was a report on the completion of accrual and preliminary findings of Dr. Jeffrey Raizer’s (Northwestern University Feinberg School of Medicine) Avastin/Tarceva (BTTC080-01) study. The meeting also featured:
Proposed studies and concepts that are...
Our Website
We're thrilled to introduce our updated website. We want to continue to provide valuable information to brain tumor patients, survivors, and their family and friends about our state-of-the-art clinical trials.
Our site continues to offer details about Brain Tumor Trials Collaborative goals, research, participating doctors and institutions. Plus, you can learn more about brain cancer.
We also want to ask for your help. Find out how you can contribute in defeating brain cancer.
Brain Tumor Support
Victims and Their Families Yearn for Information
About 612,000 people in the U.S are living with the diagnosis of a primary brain (malignant or non-malignant) or central nervous system tumor.1 The American Brain Tumor Association estimates about 64,530 men, women and children were newly diagnosed in 2011 with a primary brain tumor. This includes both malignant (24,070) and non-malignant (40,470) brain tumors.
Based on these statistics,...
Get Involved
The BTTC, like many research organizations, relies heavily on public contributions and donations to conduct and pursue its state-of-the-art clinical trials. Fundraising is BTTC's lifeblood. This is where you can get involved. Begin by visiting the Head for the Cure Foundation, BTTC's supporting partner.
